Modular Medical, Inc. — fact timeline

Modular Medical, Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at approximately $3.375 million (effective 2026-04-19).

“On April 19, 2026, Modular Medical, Inc. (the “Company”) entered into a Placement Agency Agreement (the “Agreement”) with Maxim Group LLC (the “Placement Agent”), relating to a registered direct offering (the “Offering”) of 750,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), referred to as the “Shares.” The gross proceeds to the Company from the Offering will be approximately $3.375 million”

Modular Medical, Inc.: Filed certificate of amendment to effect a one-for-thirty reverse stock split of common stock (effective 2026-03-31).

“On March 30, 2026, Modular Medical, Inc. (the “Company”) filed a certificate of amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Nevada (the “Amendment”) to effect a one (1)-for-thirty (30) reverse stock split of the Company’s shares of common stock (the “Common Stock”), par value $0.001 per share (the “Reverse Split”).”

Modular Medical, Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at cash fee equal to 7% of the gross proceeds (effective 2026-03-03).

“On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses. Pursuant to the Placement Agency Agreement, the Company paid the Placement Agent a cash fee equal to 7% of the gross proceeds received from the Offering and reimbursed the Placement Agent for its expe”

Modular Medical, Inc. entered into Securities Purchase Agreements with multiple investors valued at gross proceeds of approximately $12 million (effective 2026-03-03).

“On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses.”

Modular Medical, Inc. incurred revolving credit of $350,000 revolving credit facility with James E. Besser at 12% maturing March 25, 2026.

“On February 23, 2026, Modular Medical, Inc. (the “Company”) issued a secured promissory note (the “Note”) to James E. Besser (“the Lender”), the Company’s chief executive officer, that provides the Company with a $350,000 revolving credit facility with all amounts being drawn down by the Company thereunder being due and payable, subject to acceleration in the event of a default, on March 25, 2026 (the “Maturity Date”). Interest at the rate of 12% is payable on each draw down without regard to the draw down date or the date when interest is paid.”

Modular Medical, Inc.: Increased authorized shares of common stock from 100,000,000 to 250,000,000 (effective 2026-01-23).

“On January 23, 2026, Modular Medical, Inc. (the "Company") filed a certificate of amendment to its Amended and Restated Articles of Incorporation (as amended, the "Amended and Restated Certificate of Incorporation") (the "Charter Amendment"), with the secretary of state of the state of Nevada to increase the Company’s authorized shares of common stock from 100,000,000 to 250,000,000.”

Modular Medical, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“December 30, 2025, the Company received written notification from the Listing Qualifications Department of Nasdaq, granting the Company’s request for a 180-day extension to regain compliance with the Bid Price Rule. The Company now has until June 29, 2026 to meet the requirement. If at any time prior to June 29, 2026, the bid price of the Common Stock closes at $1 per share or more for a minimum of 10 consecutive business days, the Company will regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid Price Rule during the additional 180-day extension, N”

Modular Medical, Inc. entered into Underwriting Agreement with Newbridge Securities Corporation valued at approximately $4.68 million (effective 2025-12-10).

“On December 10, 2025, Modular Medical, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with Newbridge Securities Corporation (the “Underwriter”), relating to a firm commitment underwritten offering (the “Offering”) of (i) 12,173,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), referred to as the “Firm Shares,” and (ii) accompanying warrants exercisable to purchase up to 6,086,500 shares of Common Stock (the “Warrants”), referred to as the “Firm Warrants.””

Modular Medical, Inc. issued approximately 2,747,314 shares of the Company’s common stock of warrant to holders of the Outstanding Warrants for holders agreed to exercise these ... warrants at the New Exercise Price; gross proceeds of approximately $3.7 million.

“agreed to exercise these 2025 Warrants at the New Exercise Price. As a result of entering into the Warrant Letters, the Company will receive gross proceeds of approximately $3.7 million, before deducting expenses related to the Company entering into the Warrant Letters. In consideration for the holders of the Outstanding Warrants agreeing to enter into the”

Modular Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 30, 2025, Modular Medical Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock (“Common Stock”) for the 30 consecutive business days ending on June 27, 2025, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until December 29, 2025, in whic”

Jeffrey Goldberg was appointed as Director at Modular Medical, Inc..

“Effective May 22, 2025, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Jeffrey Goldberg as a member of the Board.”

Modular Medical, Inc. entered into Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2024-02-15).

“On February 15, 2024, Modular Medical, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Underwriter”), relating to a firm commitment underwritten offering (the “Offering”) of 9,090,910 shares (the “Shares”) of common stock of the Company (“Common Stock”).”

Modular Medical, Inc.: Increased authorized shares of common stock from 50,000,000 to 100,000,000 (effective 2024-02-15).

“to increase the Company's authorized shares of common stock from 50,000,000 to 100,000,000.”

Modular Medical, Inc. shareholders approved Approval of one or more adjournments of the Annual Meeting at the 2024-02-13 meeting.

“Proposal 5 – Approval of one or more adjournments of the Annual Meeting. For Against Abstain Broker Non-Vote 13,731,065 274,795 167 -”

Modular Medical, Inc. shareholders approved Ratification of the audit committee’s appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2024 at the 2024-02-13 meeting.

“Proposal 4 – Ratification of the audit committee’s appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2024. For Against Abstain Broker Non-Vote 13,928,715 55,937 22,504 -”

Modular Medical, Inc. shareholders approved Approval of an amendment of the Articles of Incorporation, as amended, to increase the number of authorized shares of common stock from 50,000,000 shares to 100,000,000 shares at the 2024-02-13 meeting.

“Proposal 3 – Approval of an amendment of the Articles of Incorporation, as amended, to increase the number of authorized shares of common stock from 50,000,000 shares to 100,000,000 shares. For Against Abstain Broker Non-Vote 13,528,456 120,523 358,177 -”

Modular Medical, Inc. shareholders approved Amendment of the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 3,000,000 shares at the 2024-02-13 meeting.

“Proposal 2 – Amendment of the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 3,000,000 shares. For Against Abstain Broker Non-Vote 13,528,456 120,523 358,177 -”

Modular Medical, Inc. shareholders approved Election of directors to serve until the next annual meeting of shareholders at the 2024-02-13 meeting.

“Proposal 1 - Election of directors to serve until the next annual meeting of shareholders. For Withheld Broker Non-Vote Duane DeSisto 11,772,616 4,263 2,230,277”

Modular Medical, Inc. entered into ATM Agreement with Leerink Partners LLC valued at up to $6,500,000 (effective 2023-11-22).

“On November 22, 2023, Modular Medical, Inc. (the "Company") entered into a Sales Agreement (the "ATM Agreement") with Leerink Partners LLC ("Leerink") under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company’s common stock, par value $0.001 per share (the "Common Stock"), for aggregate gross proceeds of up to $6,500,000 through an "at the market offering" program under which Leerink will act as sales agent or principal.”

Duane DeSisto was appointed as Director at Modular Medical, Inc..

“On July 5, 2023, the Board appointed Duane DeSisto, 68, to serve as a member of the Board and to chair the Compensation Committee of the Board, effective immediately.”

William Febbo resigned as Director at Modular Medical, Inc..

“On July 5, 2023, William Febbo resigned from the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) effective immediately.”

Modular Medical, Inc. entered into Underwriting Agreement with Newbridge Securities Corporation valued at aggregate gross proceeds of $9,400,000 (effective 2023-05-15).

“On May 15, 2023, Modular Medical, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Newbridge Securities Corporation (“Newbridge” or the “Underwriter”), with respect to the issuance and sale in a firm commitment underwritten offering (the “Offering”) by the Company of units of its securities for aggregate gross proceeds of $9,400,000.”

Modular Medical, Inc. shareholders approved Approval of one or more adjournments of the Annual Meeting at the 2023-01-17 meeting.

“Proposal 6 – Approval of one or more adjournments of the Annual Meeting. For Against Abstain Broker Non-Vote 7,659,802 155,549 167 —”

Modular Medical, Inc. shareholders approved Ratification of the audit committee’s appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023 at the 2023-01-17 meeting.

“Proposal 5 – Ratification of the audit committee’s appointment of Farber Hass Hurley LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023. For Against Abstain Broker Non-Vote 7,814,759 39 720 —”

Modular Medical, Inc. shareholders approved Recommendation, on a non-binding advisory basis, on the frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2023-01-17 meeting.

“Proposal 4 – Recommendation, on a non-binding advisory basis, on the frequency of future advisory votes on the compensation of the Company’s named executive officers. One Year Two Years Three Years Abstain 671,818 4,799 5,664,961 —”

Modular Medical, Inc. shareholders approved Approval, on an advisory basis, of the executive compensation of the Company's named executive officers at the 2023-01-17 meeting.

“Proposal 3 – Approval, on an advisory basis, of the executive compensation of the Company's named executive officers. For Against Abstain Broker Non-Vote 6,263,648 28,468 49,462 1,473,940”

Modular Medical, Inc. shareholders approved Amendment of the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 2,000,000 shares at the 2023-01-17 meeting.

“Proposal 2 – Amendment of the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 2,000,000 shares. For Against Abstain Broker Non-Vote 6,135,990 156,846 48,742 1,437,940”

Modular Medical, Inc. shareholders approved Election of directors to serve until the next annual meeting of shareholders at the 2023-01-17 meeting.

“Proposal 1 – Election of directors to serve until the next annual meeting of shareholders. For Withheld Broker Non-Vote Paul DiPerna 6,316,874 24,074 1,473,940 William Febbo 6,223,061 118,517 1,473,940 Steven Felsher 6,085,541 256,037 1,473,940 Morgan Frank 6,316,874 24,074 1,473,940 Philip Sheibley 6,337,468 4,110 1,473,940 Carmen Volkart 6,232,034 109,544 1,473,940 Ellen O’Connor Vos 6,060,874 280,704 1,473,940”

Modular Medical, Inc. entered into Lease Agreement with Michael Summers valued at $36,000 (effective 2023-01-05).

“On January 5, 2023, Modular Medical, Inc. (the “Company”) entered into a Lease Agreement (the “Lease Agreement”) with Michael Summers (the “Lessor”) pursuant to which the Company will lease approximately 24,000 square feet of a building located at 10740 Thornmint Road, San Diego, California, commencing on or about February 1, 2023.”

Kevin Schmid was appointed as Chief Operating Officer at Modular Medical, Inc..

“On July 21, 2022, the Board of Directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Kevin Schmid as Chief Operating Officer of the Company.”

James Besser was appointed as Chief Executive Officer at Modular Medical, Inc..

“the Board appointed Mr. James Besser, 46, as the Company’s Chief Executive Officer”

Ellen O'Connor Vos resigned as Chief Executive Officer at Modular Medical, Inc..

“On February 23, 2022, Ellen O’Connor Vos informed the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) that she was resigning from her position as Chief Executive Officer of the Company, effective immediately”

Liam Burns resigned as director at Modular Medical, Inc..

“On December 31, 2021, Liam Burns resigned from his position as a member of the board of directors (the "Board") of Modular Medical, Inc. (the "Company").”

Philip Sheibley was appointed as Director at Modular Medical, Inc..

“Effective November 29, 2021, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Steven Felsher and Philip Sheibley as members of the Board.”

Steven Felsher was appointed as Director at Modular Medical, Inc..

“Effective November 29, 2021, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Steven Felsher and Philip Sheibley as members of the Board.”

Stephen Daly resigned as Chief Commercial Officer at Modular Medical, Inc..

“On September 14, 2021, Stephen Daly submitted his resignation as Chief Commercial Officer of Modular Medical, Inc. (the “Company”), effective on or about September 24, 2021.”

Ellen O'Connor Vos was appointed as Chief Executive Officer at Modular Medical, Inc..

“Effective August 11, 2021, the Board appointed Ellen O’Connor Vos, a member of the Board since May 18, 2021, as chief executive officer of the Company.”

Paul DiPerna resigned as Chief Executive Officer at Modular Medical, Inc..

“Effective August 11, 2021, Paul DiPerna resigned as chief executive officer of Modular Medical, Inc. (the “Company”).”